https://scholars.lib.ntu.edu.tw/handle/123456789/580332| Title: | Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial | Authors: | ANN-LII CHENG Kang Y.-K. Chen Z. Tsao C.-J. Qin S. Kim J.S. Luo R. Feng J. Ye S. Yang T.-S. Xu J. Sun Y. Liang H. Liu J. Wang J. Tak W.Y. Pan H. Burock K. Zou J. Voliotis D. Guan Z. |
Issue Date: | 2009 | Journal Volume: | 10 | Journal Issue: | 1 | Start page/Pages: | 25-34 | Source: | The Lancet Oncology | URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-57749189578&doi=10.1016%2fS1470-2045%2808%2970285-7&partnerID=40&md5=03a2787bcaaed09328feb4aec2398a97 https://scholars.lib.ntu.edu.tw/handle/123456789/580332 |
DOI: | 10.1016/S1470-2045(08)70285-7 | SDG/Keyword: | [SDGs]SDG3 placebo; sorafenib; adult; advanced cancer; aged; alopecia; anorexia; article; ascites; Asia; China; clinical trial; controlled clinical trial; controlled study; desquamation; diarrhea; disease control; disease course; double blind procedure; drug dose reduction; drug efficacy; drug safety; drug tolerability; drug withdrawal; fatigue; female; hand foot syndrome; human; hypertension; interactive voice response system; liver cell carcinoma; liver dysfunction; liver function; major clinical study; male; medical decision making; multicenter study; multiple cycle treatment; nausea; outcome assessment; overall survival; phase 3 clinical trial; priority journal; randomized controlled trial; rash; South Korea; Taiwan; treatment outcome; upper gastrointestinal bleeding; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Benzenesulfonates; Carcinoma, Hepatocellular; Cost-Benefit Analysis; Double-Blind Method; Female; Humans; Liver Neoplasms; Male; Middle Aged; Protein Kinase Inhibitors; Pyridines |
| Appears in Collections: | 醫學系 |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.